Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Tekmira: Too Much, Too Soon?
Barron's
Monday, October 6, 2014 - 10:55am
tags:
Tekmira Pharmaceuticals, TKM-EBOLA, ebola virus
Chimerix Wants Its Piece of the Ebola Pie
24/7 Wall St
Monday, October 6, 2014 - 10:54am
tags:
Chimerix, ebola virus, Brincidofovir
Fierce Biotech's Top Women in Biotech 2014
Fierce Biotech
Monday, October 6, 2014 - 9:48am
tags:
biotech
Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women's Health
NASDAQ.com
Monday, October 6, 2014 - 9:46am
tags:
Teva Pharmaceutical, R&D, oncology, Women's Health
Actavis buying Durata Therapeutics for $616.4
Yahoo/AP
Monday, October 6, 2014 - 9:18am
tags:
Actavis, Durata Therapeutics, M&A
AstraZeneca heart drug gets preferred status in U.S.
Yahoo/Reuters
Monday, October 6, 2014 - 8:40am
tags:
AstraZeneca, Brilinta, acute coronary syndrome
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Monday, October 6, 2014 - 7:42am
tags:
Gilead Sciences, Sovaldi, Harvoni, Zydelig
Alcobra ADHD Drug Fails Key Study Except When Patients Removed From Analysis
TheStreet.com
Monday, October 6, 2014 - 7:40am
tags:
Alcobra, ADHD, MDX
Becton Dickinson to Buy CareFusion in Deal Valued at $12.2 Billion
TheStreet.com
Monday, October 6, 2014 - 7:30am
tags:
Becton Dickinson, CareFusion, M&A, devices
Novartis works with Bristol-Myers Squibb to test lung cancer drugs
Yahoo/Reuters
Monday, October 6, 2014 - 7:29am
tags:
Novartis, Bristol-Myers Squibb, lung cancer, Opdivo
The Stunning Mobile Game Changer for Diabetics That Investors Can't Ignore
Motley Fool
Sunday, October 5, 2014 - 10:11am
tags:
Apple, Medtronic, Guardian Mobile, diabetes, DexCom, Senseonics, type 1 diabetes
Record Number of Clinical Trials for Multiple Myeloma this Year
Drug Discovery and Development
Sunday, October 5, 2014 - 10:05am
tags:
Multiple Myeloma
What Are The Best Bets In Biotech?
Investopedia
Sunday, October 5, 2014 - 9:58am
tags:
Amgen, Gilead
'Isis' name association a plague for businesses
triblive, PA
Saturday, October 4, 2014 - 10:15am
tags:
Isis Pharmaceuticals
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
Saturday, October 4, 2014 - 10:12am
tags:
TH-302, Threshold Pharmaceuticals, glioblastoma, brain cancer
Allergan CEO resigns from Edwards Lifesciences' board
Yahoo/Reuters
Saturday, October 4, 2014 - 9:47am
tags:
Allergan, Edwards Lifesciences
Endo Accused of Conspiring to Delay Generic Version of Opana
Bloomberg
Saturday, October 4, 2014 - 9:43am
tags:
Endo, Opana, generics
Baxter Gets Shot In The Arm From Rockwell Deal
Investor's.com
Saturday, October 4, 2014 - 9:41am
tags:
Baxter, Rockwell Medical
Genentech Sales Reps Face Hospital Bans Over a Wholesale Change
WSJ Pharmalot
Friday, October 3, 2014 - 7:32pm
tags:
Genentech, drug reps, hospitals, distribution
Allergan Tips to Valeant in Deal Chain Reaction: Real M&A
Bloomberg
Friday, October 3, 2014 - 4:43pm
tags:
Allergan, Valeant Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.